Skip to content

INLEC

Active Public limited companyfounded 1981active for 45 yearsAnspachlaan 61, 1000 BrusselsKBO/BCE: BE 0421.767.678

Lifetime

20 annual accounts with figures on one time axis, 44 filings since 1982
peak of €1.7m in 2016
€771,406▼ 13.7%
lowest -€307,427 in 2019
-€11,916▼ €279,314
peak of €7.8m in 2022
€5.5m▼ 0.6%
€2.1m▼ 1.9%
peak of 21.4 FTE in 2015
3 FTE▼ 6.3%
Board2 names since 2021
2 directors and 1 other
Documentsfilings and deeds
29-07-20262 days before the deadline
2025abbreviated format
Gross margin from €893,404 to €771,406Loss of €11,916Cash from €16,350 to €63,703

Key points

from the 2025 annual accounts

Result

-€11,916 -€11,916
€267,0002024-€11,9002025

From profit to loss in 2025, after a profit of €267,398 in 2024.

Turnover

≈ €2.7m estimated

The abbreviated format states no turnover.

Investments

€23,741 0.1 times depreciation
20212022202320242025

Green is investment, beige is depreciation.

Staff

3 FTE from 21.4 in 2015

Between 2015 and 2025, the number of full-time equivalents fell by 86%.

Filings

44 annual accounts since 1982
AprilJune31 JulyOctober199520102025

Three of the last ten came late. The 2024 accounts came in latest, 61 days after the end of the period.

Position in the sector

€5.5m

More equity than 95% of companies in retail trade. The sector median is €314,317, over 13,318 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 12,350 companies had the same profile as INLEC has now. Each dot stands for 31 companies, two years later.

90.2%
were still trading
8.7%
stopped another way
0.7%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a small loss

Another 0.4% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 12,350 companies, not a prediction for INLEC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0421767678
Demerger: INLEC splits off to LECLIN The capital fell from €62,122.12 to €40,704.52 · The capital rose from €40,704.52 to €61,500 · , and resign · General meeting of 13-09-2023 · Gazette deed
Demerger proposal: INLEC splits off to LECLIN Board meeting of 31-05-2023 · Gazette deed
3 directors reappointed , (managing director) and · Gazette deed
All 63 events

Comparable companies

same main activity, similar in size and age
Company
INLEC Brussels €7.8m €0.8m 71.4% 3
COMPAGNIE FONCIERE ET FINANCIERE Celles (lez-Tournai) €7.7m €0.9m 33.7% 3
Farmathé Menen €7.4m €0.6m 89.2% 2
Apotheek Lox Leuven €5.3m €0.5m 69.5% 4.4
APOTHEEK LEROY Antwerp €4.0m €1.0m 74.6% 3.8
APOTHEEK BOXBERG Genk €4.4m €0.5m 4.7% 2.1
NERUM Heusden-Zolder €6.5m €1.3m 88.3% 5.4

These companies have the same main activity as INLEC: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €4m and €7.7m, founded between 1986 and 1995.

Official details

Source: KBO
Status
Active since 06-08-1981Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Establishment units
2.019.207.0321000 Brussels, since 31-03-1981
2.019.206.9331050 Ixelles, since 10-10-1986and 4 others
Financial year end
31 December
Peppol
Reachable since 21-10-2026
Company details

Annual accounts 2025

€7.8m▼ 1.0%
Employeeson 31-12-2025
3=
Filing
Filed on 29-07-2026, 2 days before the end of the filing period
Financials

Insights on INLEC

INLEC files the abbreviated format. That format states no turnover. The gross margin fell from €1.1m in 2006 to €771,406 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about INLEC

What is the company number of INLEC?
The company number of INLEC is 0421.767.678. The VAT number is the same number with BE in front: BE 0421.767.678.
Where is INLEC based?
The registered office is at Anspachlaan 61, 1000 Brussels.Company details
What does INLEC do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of INLEC?
INLEC is a public limited company (NV).
When was INLEC founded?
INLEC was founded on 06-08-1981.
Is INLEC still active?
Yes, INLEC is an active enterprise in the KBO register.
How many employees does INLEC have?
INLEC had an average of 3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of INLEC?
The turnover in financial year 2025 is about €2.7m. This figure is estimated from the gross margin of €771,406 and 42 comparable companies (NACE 477). It probably lies between €2.1m and €3.7m.
Is INLEC profitable?
In financial year 2025, INLEC made a loss of €11,916.
Where can I find the annual accounts of INLEC?
INLEC filed 44 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of INLEC due?
INLEC must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.